David Toapanta
Impact in
- Hepatology top 10%
- Liver Disease and Transplantation
- Liver physiology and pathology
-
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Liver Disease and Transplantation 8
- Hepatocellular Carcinoma Treatment and Prognosis 1
-
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- Javier Fernández (4 shared papers)Octavi Bassegoda (4 shared papers)Ingrid W. Zhang (1 shared paper)Benoît Colsch (1 shared paper)Cristina López‐Vicario (1 shared paper)Mireia Casulleras (1 shared paper)Roger Flores‐Costa (1 shared paper)María Hernández‐Tejero (2 shared papers)
In The Last Decade
David Toapanta
14 papers receiving 151 citations
Peers
Comparison fields: 5 of 44
- Hepatology 57
- Pharmacology 25
- Epidemiology 44
- Internal Medicine 4
- Infectious Diseases 10
Countries citing papers authored by David Toapanta
This map shows the geographic impact of David Toapanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Toapanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Toapanta more than expected).
Fields of papers citing papers by David Toapanta
This network shows the impact of papers produced by David Toapanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Toapanta. The network helps show where David Toapanta may publish in the future.
Co-authors
The 25 scholars most cited alongside David Toapanta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 71 | |
| 2 | 2022 | 21 | |
| 3 | 2024 | 17 | |
| 4 | 2022 | 14 | |
| 5 | 2023 | 7 | |
| 6 | 2021 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2021 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2023 | 2 | |
| 11 | 2021 | 2 | |
| 12 | 2025 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2023 | 0 |
About David Toapanta
David Toapanta is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Pharmacology, having authored 17 papers that have together received 153 indexed citations. Recurring topics across this work include Liver Disease and Transplantation (8 papers), Liver Disease Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Long-Term Effects of COVID-19 (2 papers), Organ Transplantation Techniques and Outcomes (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and Renal function and acid-base balance (1 paper). The work is most often cited by research in Hepatology (57 citations), Pharmacology (25 citations), Epidemiology (44 citations), Internal Medicine (4 citations) and Infectious Diseases (10 citations). David Toapanta has collaborated with scholars based in Spain, Canada and Russia. Frequent co-authors include Javier Fernández, Octavi Bassegoda, Ingrid W. Zhang, Benoît Colsch, Cristina López‐Vicario, Mireia Casulleras, Roger Flores‐Costa, María Hernández‐Tejero, Ferrán Aguilar and Ana M. Aransay. Their work appears in journals such as Journal of Hepatology, Clinical Kidney Journal, Liver International, Cardiorenal Medicine and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.